Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
BIO-TECHNE Corp (TECH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4/A
| Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 148 restricted stock units
@ $0
Granted 16,302 options to buy
@ $84.61, valued at
$1.4M
|
|
| 08/23/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 08/17/2023 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 12,798 restricted stock units
@ $0
Granted 34,442 options to buy
@ $84.61, valued at
$2.9M
Granted 45,923 options to buy
@ $84.61, valued at
$3.9M
|
|
| 08/17/2023 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 8,191 restricted stock units
@ $0
Granted 22,043 options to buy
@ $84.61, valued at
$1.9M
Granted 29,391 options to buy
@ $84.61, valued at
$2.5M
|
|
| 08/17/2023 |
4
| Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 4,432 restricted stock units
@ $0
Granted 11,928 options to buy
@ $84.61, valued at
$1M
Granted 15,904 options to buy
@ $84.61, valued at
$1.3M
|
|
| 08/17/2023 |
4
| Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Exercised 17,632 shares
@ $0
Paid exercise price by delivering 8,675 shares
@ $84.61, valued at
$734k
Granted 59,095 restricted stock units
@ $0 |
|
| 08/17/2023 |
4
| Geist William (PRESIDENT, PROTEIN SCIENCES) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 8,377 restricted stock units
@ $0
Granted 22,544 options to buy
@ $84.61, valued at
$1.9M
Granted 30,059 options to buy
@ $84.61, valued at
$2.5M
|
|
| 08/11/2023 |
4
| Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Gifted 9,008 shares
@ $0 |
|
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 6,335 shares
@ $82.17, valued at
$520.5k
Exercised 12,876 restricted stock units
@ $0 |
|
| 08/08/2023 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 4,139 shares
@ $82.17, valued at
$340.1k
Exercised 8,060 restricted stock units
@ $0 |
|
| 08/08/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 390,727 shares
@ $81.63, valued at
$31.9M
Exercised 616,676 options to buy
@ $26.65, valued at
$16.4M
|
|
| 06/09/2023 |
4
| Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 322 shares
@ $83, valued at
$26.7k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 6,778 restricted stock units
@ $0
Granted 3,928 options to buy
@ $73.76, valued at
$289.7k
|
|
| 04/04/2023 |
3
| Bohnen Shane (SVP - General Counsel) has filed a Form 3 on BIO-TECHNE Corp |
| 04/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/01/2023 |
8-K
| Quarterly results |
| 02/07/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/02/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION |
| 01/20/2023 |
SC 13G
| BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION |
| 01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
|
|
|